HuGE Literature Finder
Records
1
-
30
| Age-dependent genomic characteristics and their impact on immunotherapy in lung adenocarcinoma. Journal of cancer research and clinical oncology 2022 Jul . Li Peng, Che Shuyu, Qi Yingxue, Luo Ningning, Lin Qiuju, Zhu Xiaofeng, Xuan Yunpeng, Li Mengmeng, Li Jinlong, Ge Minghui, Sun Tingting, Qi Chuang, Wang Yongj |
| Association between squamous cell carcinoma antigen level and EGFR mutation status in Chinese lung adenocarcinoma patients. Journal of clinical laboratory analysis 2022 Jul e24613. Zhang Shuying, Gao Jianxiong, Niu Rong, Ye Jiru, Ma Jinhong, Jiang Lijuan, Shao Xiaon |
| Clinicopathologic and genomic features of high-grade pattern and their subclasses in lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2022 Jul 170 176-184. Ahn Bokyung, Yoon Shinkyo, Kim Deokhoon, Chun Sung-Min, Lee Goeun, Kim Hyeong-Ryul, Jin Jang Se, Sang Hwang H |
| A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib. BMC medical genomics 2022 Jun 15 (1): 141. Chen Yan, Jiang Bo, He Yuange, Zhang Chu, Zhou Wenjie, Fang Cheng, Gu Dejian, Zhang Minxia, Ji Mei, Shi Juntao, Yang X |
| B7-H3 is eligible for predicting clinical outcomes in lung adenocarcinoma patients treated with EGFR tyrosine kinase inhibitors. World journal of surgical oncology 2022 May 20 (1): 159. Yang Ying, Huang Jun-Feng, Hu Bing-Qi, Zhou Jing, Wang Xian, Feng Zhen-Zhong, Chen Yu-Ting, Pan Fa-Ming, Cheng Huai-Dong, Chen Li-W |
| Cytoplasmic expression of G protein-coupled estrogen receptor 1 correlates with poor postoperative prognosis in non-small cell lung cancer. Journal of thoracic disease 2022 May 14 (5): 1466-1477. Li Zhen-Hua, Liu Chang, Liu Qing-Hua, Wang Jian, Wang Ying, Wang Yan-Fei, Deng Shou-Jun, Li Ding-Bi |
| Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome. Human pathology 2022 May 126 9-18. Chang Wei-Chin, Yeh Yi-Chen, Ho Hsiang-Ling, Chou Teh-Yi |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China. Genes and environment : the official journal of the Japanese Environmental Mutagen Society 2022 May 44 (1): 17. Wang Jun-Ling, Fu Yu-Dong, Gao Yan-Hong, Li Xiu-Ping, Xiong Qian, Li Rui, Hou Bo, Huang Ruo-Shan, Wang Jun-Feng, Zhang Jian-Kun, Lv Jia-Ling, Zhang Chao, Li Hong-W |
| Dynamic changes in the systemic immune-inflammation index predict the prognosis of EGFR-mutant lung adenocarcinoma patients receiving brain metastasis radiotherapy. BMC pulmonary medicine 2022 Mar 22 (1): 75. Wang Qi, Tan Xiaojing, Deng Guangchuan, Fu Shuai, Li Jianbin, Li Zhenxia |
| A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection. Translational lung cancer research 2022 Jan 11 (1): 24-42. Hu Chunhong, Shu Long, Chen Chen, Fan Songqing, Liang Qingchun, Zheng Hongmei, Pan Yue, Zhao Lishu, Zou Fangwen, Liu Chaoyuan, Liu Wenliang, Yu Feng-Lei, Liu Xianling, Liu Lijuan, Yang Lingling, Shao Yang, Wu Fa |
| Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions. The clinical respiratory journal 2022 Jan . Liu Qinghua, Huang Qingyan, Yu Zhikang, Wu Hemi |
| Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
| Genetic alteration and PD-L1 expression profiles of Chinese patients with lung squamous cell carcinoma. Pathology, research and practice 2022 Jan 231 153761. Chen Ying, Kong Wencui, Yu Zongyang, Zhao Zhongqu |
| Loss of STING expression is prognostic in non-small cell lung cancer. Journal of surgical oncology 2022 Jan . Lohinai Zoltan, Dora David, Caldwell Charles, Rivard Christopher J, Suda Kenichi, Yu Hui, Rivalland Gareth, Ellison Kim, Rozeboom Leslie, Dziadziuszko Rafal, Mitchell Paul, John Thomas, Millan Inigo S, Ren Shengxiang, Hirsch Fred |
| Predictive value of multiple metabolic and heterogeneity parameters of Annals of nuclear medicine 2022 Jan . Shi Aiqi, Wang Jianling, Wang Yuzhu, Guo Guorong, Fan Chouchou, Liu Jiangy |
| Pretreatment neutrophil-to-lymphocyte ratio and cigarette smoking as prognostic factors in patients with advanced NSCLC treated with osimertinib. Tuberculosis and respiratory diseases 2022 Jan . Park Ji Young, Jang Seung Hun, Lee Chang Youl, Kim Taehee, Chung Soo Jie, Lee Ye Jin, Kim Hwan Il, Kim Joo-Hee, Park Sunghoon, Hwang Yong Il, Jung Ki-Su |
| Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC. Emergency medicine international 2022 2022 3112281. Qiao Man, Li Dongsheng, He Yuan, Zhang Cen, Chi Hang, Li Xiaoqiu, Cui QingMing, Li ShaoYing, Jiao Ying, Wei Yu |
| Development of a Nomogram Based on 3D CT Radiomics Signature to Predict the Mutation Status of EGFR Molecular Subtypes in Lung Adenocarcinoma: A Multicenter Study. Frontiers in oncology 2022 12 889293. Zhang Guojin, Deng Liangna, Zhang Jing, Cao Yuntai, Li Shenglin, Ren Jialiang, Qian Rong, Peng Shengkun, Zhang Xiaodi, Zhou Junlin, Zhang Zhuoli, Kong Weifang, Pu Ho |
| Gene Mutation and Its Association with Clinicopathological Features in Young Patients with Non-Small-Cell Lung Cancer. Emergency medicine international 2022 2022 6333282. Kong Wencui, Yu Zongyang, Wang Wenwu, Yang Jingrong, Wang Jingfang, Zhao Zhongqu |
| Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics. PloS one 2022 17 (1): e0262822. Li Fanghua, Ye Peng, Cai Peiling, Dong Dandan, Zhang Yihao, Yang Yue, Sun Xingwa |
| Microsatellite Instability Is Rare in the Admixed Brazilian Population of Non-Small Cell Lung Cancer: A Cohort of 526 Cases. Pathobiology : journal of immunopathology, molecular and cellular biology 2021 Nov 1-6. De Marchi Pedro, Berardinelli Gustavo Noriz, Cavagna Rodrigo de Oliveira, Pinto Icaro Alves, da Silva Flavio Augusto Ferreira, Duval da Silva Vinicius, Santana Iara Viana Vidigal, da Silva Eduardo Caetano Albino, Ferro Leal Leticia, Reis Rui Manu |
| NF1-Mutant Cancer and Immune Checkpoint Inhibitors: A Large Database Analysis. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e421. Li X, Yu J, Wang |
| Prediction model based on 18F-FDG PET/CT radiomic features and clinical factors of EGFR mutations in lung adenocarcinoma. Neoplasma 2021 Nov . Zhao Hong-Yue, Su Ye-Xin, Zhang Lin-Han, Fu Pe |
| Development and validation of a multivariable predictive model for EGFR gene mutation status in patients with lung adenocarcinoma. Neoplasma 2021 Oct . Shi Yiping, Zha Qiongfang, Ye Qing, Xue Shan, Wu Huawei, Tang Daoqiang, Qin Hui, Zou Ji |
| Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer. Clinical lung cancer 2021 Oct . Suda Kenichi, Ohara Shuta, Fujino Toshio, Hamada Akira, Chiba Masato, Shimoji Masaki, Takemoto Toshiki, Soh Junichi, Mitsudomi Tetsu |
| Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma. Chinese medical journal 2021 Sep 134 (20): 2430-2437. Liu Xiang-Liang, Bai Ri-Lan, Chen Xiao, Zhao Yu-Guang, Wang Xu, Ma Ke-Wei, Tian Hui-Min, Han Fu-Jun, Liu Zi-Ling, Yang Lei, Li Wei, Gai Fei, Cui Jiu-W |
| Prognostic role of epidermal growth factor receptor mutation status in patients with de novo lung adenocarcinoma. Translational cancer research 2021 Mar 10 (3): 1549-1558. Li Bo, Ren Xiaolu, Guo Hongxia, Guo Yi, Han Fei, Wen Xiaolian, Wu Jing, Li Xiaomin, Ren Yuejun, Hu Xiaoyun, Liu Zhiho |
| Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma. Frontiers in oncology 2021 11 732841. Li Jia, Li Huahua, Zhang Chenyue, Zhang Chenxing, Jiang Lifeng, Wang Haiyong, Liu Huaim |
| The relationship between PD-L1 expression and tumor driver gene mutations and survival in non small cell lung carcinoma. Polish journal of pathology : official journal of the Polish Society of Pathologists 2021 72 (3): 222-228. Chan Kin, Vong Hong, Chu Wai, Cheng Kun, Zhong Xue, Wen Ji |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 18, 2022
- Content source: